A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease

被引:32
作者
Matera, MG
Caputi, M
Cazzola, M
机构
[1] UNIV NAPLES 2,SCH MED,INST PHARMACOL & TOXICOL,NAPLES,ITALY
[2] UNIV NAPLES 2,SCH MED,INST RESP MED,NAPLES,ITALY
[3] A CARDARELLI HOSP,RESP CLIN PHARMACOL UNIT,NAPLES,ITALY
[4] A CARDARELLI HOSP,DIV PNEUMOL & ALLERGOL,NAPLES,ITALY
关键词
D O I
10.1016/S0954-6111(96)90178-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:497 / 499
页数:3
相关论文
共 14 条
[1]  
AIKAWA H, 1991, RESPIRATION, V58, P163
[2]  
BAI T R, 1989, Pulmonary Pharmacology, V1, P193, DOI 10.1016/S0952-0600(89)80017-1
[3]  
BAKER DG, 1982, PHYSIOLOGIST, V25, P225
[4]   MODULATION OF NEUROTRANSMISSION IN AIRWAYS [J].
BARNES, PJ .
PHYSIOLOGICAL REVIEWS, 1992, 72 (03) :699-729
[5]  
Barnes PJ, 1995, Chronic Obstructive Pulmonary Disease, P391, DOI 10.1007/978-1-4899-4525-9_16
[6]   SALMETEROL AND FORMOTEROL IN PARTIALLY REVERSIBLE SEVERE CHRONIC OBSTRUCTIVE PULMONARY-DISEASE - A DOSE-RESPONSE STUDY [J].
CAZZOLA, M ;
MATERA, MG ;
SANTANGELO, G ;
VINCIGUERRA, A ;
ROSSI, F ;
DAMATO, G .
RESPIRATORY MEDICINE, 1995, 89 (05) :357-362
[7]   EFFECT OF SALMETEROL AND FORMOTEROL IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
CAZZOLA, M ;
SANTANGELO, G ;
PICCOLO, A ;
SALZILLO, A ;
MATERA, MG ;
DAMATO, G ;
ROSSI, F .
PULMONARY PHARMACOLOGY, 1994, 7 (02) :103-107
[8]  
CHAPMAN KR, 1991, RES CLIN FORUMS, V13, P43
[9]  
HUMPHREYS DM, 1991, RES CLIN FORUMS, V13, P7
[10]   COMPARATIVE DOSE-RESPONSE STUDY OF 3 ANTICHOLINERGIC AGENTS AND FENOTEROL USING A METERED-DOSE INHALER IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
IKEDA, A ;
NISHIMURA, K ;
KOYAMA, H ;
IZUMI, T .
THORAX, 1995, 50 (01) :62-66